IP Library Granted Patent US 9,814,464
Granted Patent B2
US 9,814,464 · App. 13/575,287 · Granted Nov 14, 2017

Post operative wound support device

Inventor: Anders Jönsson (Bromma, SE)
Assignee: AEEG AB
A61B17/12022A61B17/0057A61B17/12099A61B17/12136A61M1/008A61M1/0096A61B2017/00676A61B2017/00893A61B2017/12004A61M37/0092A61M2025/0002A61M2025/006A61M2025/0059A61M2025/1015A61M2025/1075A61M2025/1081A61M2025/1084A61M2025/1088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,464
App. No.
13/575,287
Granted
Nov 14, 2017
Kind
B2
Abstract

A wound drainage and hemostasis promoting medical device ( 1 ) are disclosed. A balloon ( 15 ) is temporary inflated and arranged outside a sheath ( 10 ), in contact with tissue surrounding a wound cavity for hemostasis promotion. The drainage device comprises a fluid communication channel for wound exudate from wound. The balloon is deflated and retracted into said sheath for removal from said wound cavity. Thus the medical device is percutaneously retractable from said confined wound.

Claims (38)

1. A medical procedure of draining exudate from a wound cavity of a post surgical confined wound and promoting hemostasis for therapeutic treatment of said wound, said procedure comprising:

surgically creating a cutaneous opening at a distance from said confined wound;

providing a medical drainage device having a fluid communication channel;

percutaneously arranging a distal end of said fluid communication channel in said wound cavity of said post surgical confined wound and a proximal end of said fluid communication channel outside of said wound cavity, and thus draining wound exudate from said distal end to said proximal end of said fluid communication channel;

cutaneously closing said confined wound;

providing a hemostasis promoting medical device having an elongate sheath, an inflatable and deflatable balloon longitudinally moveable relative to said sheath, and a hollow inflation and deflation tubular member along said elongate sheath in fluid communication with said balloon;

percutaneously arranging said sheath through said cutaneous opening with a proximal end of said elongate sheath outside said wound cavity and a distal end of said elongate sheath in said wound cavity with said balloon deflated in said sheath;

discharging said balloon out of said distal end of said sheath in said wound cavity thereof;

inflating said balloon to a desired pressure through said tubular member to be at least partly in apposition with tissue surrounding said wound cavity for said hemostasis promotion during a hemostasis promoting time; and

deflating said balloon, reloading said deflated balloon into said distal end of said sheath, and retracting said distal end of said sheath out of said wound cavity through said cutaneous opening;

wherein the procedure further comprises providing nitric oxide (NO) to tissue of said wound emanating from a liquid being a source of nitric oxide (NO) inside said balloon, said balloon being filled with said liquid when inflated and being fluid impermeable whereby the liquid source of nitric oxide (NO) is kept separate from the wound tissue, and said balloon being permeable for nitric oxide (NO); and,

providing an ultrasonic sound generator, generating ultrasonic sound waves with said ultrasonic sound generator, and propagating said ultrasonic sound waves through said liquid towards said inflated balloon and through said balloon to said surrounding tissue.

2. The procedure of claim 1 , wherein said deflated balloon is reloaded into said sheath by moving said sheath longitudinally relative to said balloon, including retracting said hollow tubular member and thus said balloon into said sheath, or pushing said sheath over said deflated balloon.

3. The procedure of claim 1 , wherein said hemostasis promoting time is between six and twenty-four hours before deflating said balloon and withdrawing said medical drainage device.

4. The procedure of claim 1 , wherein said procedure is a non-acute, planned procedure initiated during termination of a surgical intervention.

5. The procedure of claim 1 , wherein said surgical intervention is a thorax surgical intervention and said procedure comprises preventing a tamponage by draining said wound cavity.

6. The procedure of claim 1 , comprising applying a gas pressure to said distal end of said fluid communication channel wherein said gas pressure is lower than a gas pressure in said wound cavity.

7. The procedure of claim 6 , comprising providing by said inflated balloon a positive mechanical pressure at said apposition with tissue surrounding said wound cavity providing said hemostasis promotion, and wherein said balloon is flexible making contact with said tissue substantially independent of a topography of said tissue surrounding said wound cavity.

8. The procedure of claim 1 or 6 , comprising providing by said inflated balloon a positive mechanical pressure at said apposition with tissue surrounding said wound cavity providing for said hemostasis promotion, and wherein said balloon is flexible making contact with said tissue substantially independent of a topography of said tissue surrounding said wound cavity.

9. The procedure of claim 1 , wherein the confined wound is not opened again during healing.

10. The procedure of claim 1 , comprising retracting said balloon after stopping of bleeding, and keeping the drainage device in place for continued wound exudate handling.

11. The procedure of claim 1 , comprising promoting coagulation by said hemostasis promoting medical device for controlling a bleeding situation.

12. The procedure of claim 1 , comprising removing said balloon and/or sheath from the wound without causing bleeding.

13. The procedure of claim 1 , comprising providing at least one pharmaceutical substance from said hemostasis promoting medical device to said wound.

14. The procedure of claim 13 , wherein said pharmaceutical substance includes at least one of an antibiotic agent, a coagulation promoting agent, or a platelet adherence inhibitor.

15. The procedure of claim 1 ,

wherein said balloon has an outer surface that is hydrophobic.

16. A medical procedure of draining exudate from a wound cavity of a post surgical confined wound and promoting hemostasis for therapeutic treatment of said wound, said procedure comprising:

surgically creating a cutaneous opening at a distance from said confined wound;

providing a medical drainage device having a fluid communication channel;

percutaneously arranging a distal end of said fluid communication channel in said wound cavity of said post surgical confined wound and a proximal end of said fluid communication channel outside of said wound cavity, and thus draining wound exudate from said distal end to said proximal end of said fluid communication channel;

cutaneously closing said confined wound;

providing a hemostasis promoting medical device having an elongate sheath, an inflatable and deflatable balloon longitudinally moveable relative to said sheath, and a hollow inflation and deflation tubular member along said elongate sheath in fluid communication with said balloon;

percutaneously arranging said sheath through said cutaneous opening with a proximal end of said elongate sheath outside said wound cavity and a distal end of said elongate sheath in said wound cavity with said balloon deflated in said sheath;

discharging said balloon out of said distal end of said sheath in said wound cavity thereof;

inflating said balloon with a liquid to a desired pressure through said tubular member to be at least partly in apposition with tissue surrounding said wound cavity for said hemostasis promotion during a hemostasis promoting time;

providing an ultrasonic sound generator, generating ultrasonic sound waves with said ultrasonic sound generator, and propagating said ultrasonic sound waves through said liquid towards said inflated balloon and through said balloon to said surrounding tissue.

17. The procedure of claim 16 , wherein the procedure further comprises providing nitric oxide (NO) to tissue of said wound emanating from said liquid being a source of nitric oxide (NO) inside said balloon, said balloon being filled with said liquid when inflated and being fluid impermeable whereby the liquid source of nitric oxide (NO) is kept separate from the wound tissue, and said balloon being permeable for nitric oxide (NO).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2012
From: JONSSON, ANDERS
To: AEEG AB
Reel/Frame 028789/0992 →
Priority Claims (1)
EP 10151829 · Jan 27, 2010 · regional
Continuity (1)
Related Publication 20120316491A1 · Dec 13, 2012